Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement

被引:179
作者
Kallinich, Tilmann
Haffner, Dieter
Niehues, Tim
Huss, Kristina
Lainka, Elke
Neudorf, Ulrich
Schaefer, Christof
Stojanov, Silvia
Timmann, Christian
Keitzer, Rolf
Ozdogan, Huri
Ozen, Seza
机构
[1] Univ Med Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany
[2] Univ Hosp Rostock, Dept Pediat, Rostock, Germany
[3] Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-4000 Dusseldorf, Germany
[4] Univ Duisburg Gesamthsch, Dept Pediat, D-4100 Duisburg, Germany
[5] Childrens Univ Hosp, Dept Infect Dis & Immunol, Munich, Germany
[6] Berliner Betrieb Zent Gesundheitl Aufugaben, Berlin, Germany
[7] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany
[8] Istanbul Univ, Cerrahpasa Med Sch, Cerrahpasa, Turkey
[9] Hacettepe Univ, Fac Med, Dept Pediat Nephrol & Rheumatol, Ankara, Turkey
关键词
familial Mediterranean fever; colchicine; evidence-based guidelines; treatment;
D O I
10.1542/peds.2006-1434
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.
引用
收藏
页码:E474 / E483
页数:10
相关论文
共 145 条
  • [1] PHARMACOKINETICS - BIOAVAILABILITY OF COLCHICINE IN HEALTHY MALE-VOLUNTEERS
    ACHTERT, G
    SCHERRMANN, JM
    CHRISTEN, MO
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1989, 14 (04) : 317 - 322
  • [2] Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish Familial Mediterranean Fever patients with and without amyloidosis
    Akar, N
    Hasipek, M
    Akar, E
    Ekim, M
    Yalçinkaya, F
    Çakar, N
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (01): : 12 - 16
  • [3] The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients
    Akar, S
    Soyturk, M
    Onen, F
    Tunca, M
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (07) : 676 - 679
  • [4] Aksentijevich I, 1997, CELL, V90, P797
  • [5] Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard® -: a standardized fixed combination of Andrographis pankulata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever
    Amaryan, G
    Astvatsatryan, V
    Gabrielyan, E
    Panossian, A
    Panosyan, V
    Wikman, G
    [J]. PHYTOMEDICINE, 2003, 10 (04) : 271 - 285
  • [6] Safety of colchicine in dialysis patients
    Anderson-Hoog, T
    Patel, B
    [J]. SEMINARS IN DIALYSIS, 2003, 16 (05) : 412 - 413
  • [7] Association of FMF-Related (MEFV) point mutations with secondary and FMF amyloidosis
    Atagunduz, MP
    Tuglular, S
    Kantarci, G
    Akoglu, E
    Direskeneli, H
    [J]. NEPHRON CLINICAL PRACTICE, 2004, 96 (04): : C131 - C135
  • [8] Bakkaloglu A, 2004, J RHEUMATOL, V31, P1139
  • [9] BARKAI G, 1U ANN M EUR NETW TE
  • [10] TREATMENT OF SEVERE COLCHICINE OVERDOSE WITH COLCHICINE-SPECIFIC FAB FRAGMENTS
    BAUD, FJ
    SABOURAUD, A
    VICAUT, E
    TABOULET, P
    LANG, J
    BISMUTH, C
    ROUZIOUX, JM
    SCHERRMANN, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (10) : 642 - 645